Cargando…

Adequate Patient’s Outcome Achieved with Short Immunoglobulin Replacement Intervals in Severe Antibody Deficiencies

PURPOSE: The optimal immune globulin replacement dosages required over time to minimize infection risks in patients with Primary Antibody Deficiencies are not definitely established. As with many interventions, there may be specific subgroups of patients who are more likely to benefit from treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Milito, Cinzia, Pulvirenti, Federica, Pesce, Anna Maria, Digiulio, Maria Anna, Pandolfi, Franco, Visentini, Marcella, Quinti, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165867/ https://www.ncbi.nlm.nih.gov/pubmed/25047154 http://dx.doi.org/10.1007/s10875-014-0081-9

Ejemplares similares

Lung Magnetic Resonance Imaging with Diffusion Weighted Imaging Provides Regional Structural as well as Functional Information Without Radiation Exposure in Primary Antibody Deficiencies
por: Milito, Cinzia, et al.
Publicado: (2015)

Editorial: Immunoglobulin Therapy in the 21st Century – the Dark Side of the Moon
por: Farrugia, Albert, et al.
Publicado: (2015)

IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2020)

Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic
por: Pulvirenti, Federica, et al.
Publicado: (2020)

Longitudinal Study on Health-Related Quality of Life in a Cohort of 96 Patients with Common Variable Immune Deficiencies
por: Tabolli, Stefano, et al.
Publicado: (2014)

Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes
por: Pulvirenti, Federica, et al.
Publicado: (2016)

Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies Efficacy
por: Milito, Cinzia, et al.
Publicado: (2022)

Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter Study
por: Pulvirenti, Federica, et al.
Publicado: (2019)

Health-Related Quality of Life and Patients’ Empowerment in the Health Care of Primary Immune Deficiencies
por: Quinti, Isabella, et al.
Publicado: (2017)

Idiopathic Non Cirrhotic Portal Hypertension and Spleno-Portal Axis Abnormalities in Patients with Severe Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2014)

Health Related Quality of Life in Common Variable Immunodeficiency
por: Quinti, Isabella, et al.
Publicado: (2012)

Lack of Gut Secretory Immunoglobulin A in Memory B-Cell Dysfunction-Associated Disorders: A Possible Gut-Spleen Axis
por: Carsetti, Rita, et al.
Publicado: (2020)

The Allergic Phenotype of Children and Adolescents with Selective IgA Deficiency: A Longitudinal Monocentric Study
por: Cinicola, Bianca Laura, et al.
Publicado: (2022)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2022)

SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experience
por: Pulvirenti, Federica, et al.
Publicado: (2023)

Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency
por: Pulvirenti, Federica, et al.
Publicado: (2018)

Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014)

Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency
por: Pulvirenti, Federica, et al.
Publicado: (2021)

Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies
por: Cinetto, Francesco, et al.
Publicado: (2021)

The Usefulness of Scintigraphic Studies in the Assessment of Asymptomatic Bowel Disease in Patients with Primary Antibody Diseases
por: Milito, Cinzia, et al.
Publicado: (2020)

The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement
por: Cavaliere, Filomena Monica, et al.
Publicado: (2017)

Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022
por: Milito, Cinzia, et al.
Publicado: (2023)

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies
por: Pulvirenti, Federica, et al.
Publicado: (2021)

Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake
por: Wang, Zhaojun, et al.
Publicado: (2016)

Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic
por: Garzi, Giulia, et al.
Publicado: (2022)

Modulatory Effects of Antibody Replacement Therapy to Innate and Adaptive Immune Cells
por: Quinti, Isabella, et al.
Publicado: (2017)

Impaired memory B-cell response to the Pfizer-BioNTech COVID-19 vaccine in patients with common variable immunodeficiency
por: Fernandez Salinas, Ane, et al.
Publicado: (2022)

Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study
por: Vultaggio, Alessandra, et al.
Publicado: (2015)

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
por: Canessa, Clementina, et al.
Publicado: (2016)

COVID-19 Severity, Cardiological Outcome, and Immunogenicity of mRNA Vaccine on Adult Patients With 22q11.2 DS
por: Pulvirenti, Federica, et al.
Publicado: (2023)

Adequate interval for the monitoring of vital signs during endotracheal intubation
por: Min, J.Y., et al.
Publicado: (2017)

Intravenous Immunoglobulin and Immunomodulation of B-Cell – in vitro and in vivo Effects
por: Mitrevski, Milica, et al.
Publicado: (2015)

Case Report: Interindividual variability and possible role of heterozygous variants in a family with deficiency of adenosine deaminase 2: are all heterozygous born equals?
por: Pulvirenti, Federica, et al.
Publicado: (2023)

On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events
por: Späth, Peter J., et al.
Publicado: (2015)

Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters
por: Piano Mortari, Eva, et al.
Publicado: (2023)

SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best
por: Salinas, Ane Fernandez, et al.
Publicado: (2021)

Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
por: Borte, Michael, et al.
Publicado: (2023)

Successful Pregnancies After Adequate Hormonal Replacement in Patients With Combined Pituitary Hormone Deficiencies
por: Correa, Fernanda A., et al.
Publicado: (2017)

The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency
por: Quinti, Isabella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l2bhhku0j6l75blo3e829c13pt